Evidence map›Paper›PMID 35025894›Full record

ArticlePLoS neglected tropical diseases2022

Development of a questionnaire to determine the case detection delay of leprosy: A mixed-methods cultural validation study.

Naomi D de Bruijne, Kedir Urgesa, Abraham Aseffa, Kidist Bobosha, Anne Schoenmakers, Robin van Wijk, Thomas Hambridge, Mitzi M Waltz, Christa Kasang, Liesbeth Mieras

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Naomi D de BruijneAthena Institute, Faculty of Earth and Life Sciences, VU University, Amsterdam, Netherlands.ORCID 0000-0002-7962-4654
Kedir UrgesaArmauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia.
Abraham AseffaArmauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia.
Kidist BoboshaArmauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia.ORCID 0000-0001-8091-7182
Anne SchoenmakersNLR, Amsterdam, Netherlands.ORCID 0000-0003-3040-7883
Robin van WijkNLR, Amsterdam, Netherlands.ORCID 0000-0002-0969-4155
Thomas HambridgeErasmus University Medical Center, Rotterdam, Netherlands.ORCID 0000-0003-2600-7510
Mitzi M WaltzAthena Institute, Faculty of Earth and Life Sciences, VU University, Amsterdam, Netherlands.ORCID 0000-0002-9089-2545
Christa KasangGerman Leprosy and Tuberculosis Relief Association (DAHW), Wurzburg, Germany.ORCID 0000-0003-0241-0321
Liesbeth MierasNLR, Amsterdam, Netherlands.
Netherlands Leprosy Relief · NLArmauer Hansen Research Institute · ETAmsterdam UMC Location Vrije Universiteit Amsterdam · NLDeutsche Lepra- und Tuberkulosehilfe · DEErasmus MC · NLHaramaya University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDelay in case detection is a risk factor for developing leprosy-related impairments, leading to disability and stigma. The objective of this study was to develop a questionnaire to determine the leprosy case detection delay, defined as the period between the first signs of the disease and the moment of diagnosis, calculated in total number of months. The instrument was developed as part of the PEP4LEP project, a large-scale intervention study which determines the most effective way to implement integrated skin screening and leprosy post-exposure prophylaxis with a single-dose of rifampicin (SDR-PEP) administration in Ethiopia, Mozambique and Tanzania. METHODOLOGY/PRINCIPAL

findingsA literature review was conducted and leprosy experts were consulted. The first draft of the questionnaire was developed in Ethiopia by exploring conceptual understanding, item relevance and operational suitability. Then, the first draft of the tool was piloted in Ethiopia, Mozambique and Tanzania. The outcome is a questionnaire comprising nine questions to determine the case detection delay and two annexes for ease of administration: a local calendar to translate the patient's indication of time to number of months and a set of pictures of the signs of leprosy. In addition, a body map was included to locate the signs. A 'Question-by-Question Guide' was added to the package, to provide support in the administration of the questionnaire. The materials will be made available in English, Oromiffa (Afaan Oromo), Portuguese and Swahili via https://www.infolep.org. CONCLUSIONS/SIGNIFICANCE: It was concluded that the developed case detection delay questionnaire can be administered quickly and easily by health workers, while not inconveniencing the patient. The instrument has promising potential for use in future leprosy research. It is recommended that the tool is further validated, also in other regions or countries, to ensure cultural validity and to examine psychometric properties like test-retest reliability and interrater reliability.

Indexed as

AdolescentAdultAgedChildContact TracingCross-Sectional StudiesEthiopiaFemaleHumansLeprostatic AgentsLeprosyMaleMiddle AgedMozambiquePost-Exposure ProphylaxisReproducibility of ResultsLeprostatic AgentsRifampin

Identifiers

PMID35025894
PMCPMC8758092
OpenAlexW4205928158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.